KRAS and cancer: Wang et al. have shown that p38γ is overexpressed in pancreatic cancer, regulating KRAS oncogene signaling and aerobic glycolysis to promote tumorigenesis and cancer progression through PFKFB3-GLUT2 signaling [12].